Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey(256 views) Clemente G, Giorgini M, Mancini M, Gallo M, Amd-associazione Medici Diabetologi ‘diabetes Cancer’ worki
Diabetes Res Clin Pract (ISSN: 0168-8227linking), 2018 Sep; 143: 420-427.
Keywords: Antidiabetic Drugs, Clinical Management, Smbg, Survey, Tumors, Type 2 Diabetes Mellitus, Adult
, Blood Glucose Self-Monitoring Methods
, Type 2 Blood Drug Therapy
, Female
, Humans
, Middle Aged
, Neoplasms Complications
, Oncologists Standards
, Surveys And Questionnaires, Dipeptidyl Peptidase Iv Inhibitor, Glitazone Derivative, Insulin, Metformin, Sulfonylurea, Artificial Feeding, Blood Glucose Monitoring, Cancer Patient, Controlled Study, Counseling, Diabetologist, Diet Restriction, Disease Severity, Exploratory Research, Health Personnel Attitude, Hypoglycemia, Life Expectancy, Prevalence, Prognosis, Review, Terminally Ill Patient, Non Insulin Dependent Diabetes Mellitus, Procedures,
Affiliations: *** IBB - CNR ***
IRPPS-Institute for Research on Population and Social Policies of the Italian National Research Council, Fisciano, Salerno, Italy. Electronic address: gennaro.clemente@cnr.it.
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
IBB-Institute of Biostructure and Bioimaging, of the Italian National Research Council, Naples, Italy.
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, AOU Citta della Salute e della Scienza di Torino, Turin, Italy.
References: Handelsman, Y., Leroith, D., Bloomgarden, Z.T., Dagogo-Jack, S., Einhorn, D., Garber, A.J., Grunberger, G., Hennekens, C.H., , pp. 675-93. , http://doi.org/10.4158/EP13248.CS, Diabetes and cancer an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug
Ranc, K., Jørgensen, M.E., Friis, S., Carstensen, B., Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment (2014) Diabetologia, 57, pp. 927-93
Weiser, M.A., Cabanillas, M.E., Konopleva, M., Thomas, D.A., Pierce, S.A., Escalante, C.P., Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen (2004) Cancer, 100 (6), pp. 1179-1185
Lee, W., Yoon, Y.S., Han, H.S., Cho, J.Y., Choi, Y., Jang, J.Y., Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma (2016) J Surg Oncol, 113 (2), pp. 203-208
Psarakis, H.M., Clinical challenges in caring for patients with diabetes and cancer (2006) Diabetes Spectrum, 19 (3), pp. 157-162
Mateo, J., Castro, F., Olmos, D., (2013), pp. 72-88. , on behalf of the European Society for Medical Oncology. Cancer treatment in patients with diabetes. In 2013 ESMO Handbook on cancer treatment in special clinical situations: Edit. ESMO Press
http://www.uhb.nhs.uk/Downloads/pdf/CancerPbDiabetesMellitus.pdf, Pan Birmingham Cancer Network: Guideline for the Management of Diabetes Mellitus in Palliative Medicine. [accessed August 2017]
Diabetes, U.K., http://www.diabetes.org.uk/upload/Position%20statements/End-of-life-care-Clinical-recs111113.pdf, End of Life Diabetes Care - Clinical Care Recommendations. [accessed August 2017]
Gallo, M., Gentile, L., Arvat, E., Bertetto, O., Clemente, G., Diabetology and oncology meet in a network model: union is strength (2016) Acta Diabetol, 53, pp. 515-524
http://aemmedi.it/diabete-e-tumori/, AMD (Italian Association of Diabetologists) Working Group on “Diabetes and Cancer”. [accessed August 2017]
Poulson, J., The management of diabetes in patients with advanced cancer (1997) J Pain Symptom Manage, 13, pp. 339-346
Jacob, P., Chowdhury, T.A., Management of diabetes in patients with cancer (2015) QJM, 108, pp. 443-448
McCoubrie, R., Jeffrey, D., Paton, C., Dawes, L., Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines (2005) Eur J Cancer Care (Engl), 14 (3), pp. 244-248
Quinn, K., Hudson, P., Dunning, T., Diabetes management in patients receiving palliative care (2006) J Pain Symptom Manage, 32, pp. 275-286
Ford-Dunn, S., Smith, A., Quin, J., Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK (2006) Palliat Med, 20 (3), pp. 197-203
Dionisio, R., Giardini, A., De Cata, P., Pirali, B., Rossi, S., Negri, E.M., Diabetes management in end of life: a preliminary report stemming from clinical experience (2015) Am J Hosp Palliat Care, 32 (6), pp. 588-593
Gallo, M., Muscogiuri, G., Felicetti, F., Faggiano, A., Trimarchi, F., Arvat, E., Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes (2018) Metabolism, 78, pp. 141-154
http://www.reteoncologica.it/area-operatori/terapie-di-supporto/raccomandazioni-terapie-di-supporto, Rete Oncologica Piemonte-Valle d'Aosta. Protocollo per la gestione del paziente oncologico con diabete mellitoUR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044727563&doi=10.1016%2fj.diabres.2018.02.044&partnerID=40&md5=c33f361b66075f03843223b61d48d36e
Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey